OnKure Therapeutics, Inc. Class A OKUR 深 滬
等待開盤 08-10 09:30:00 美东时间
4.14
-0.010
-0.24%
華盛通- 最 高4.26
- 今 開4.24
- 成交量 8.50万股
- 最 低 4.01
- 昨 收 4.15
- 總市值 1.68亿
- 52周最高 5.38
- 市盈率 靜 --
- 換手率 0.21%
- 52周最低 2.23
- 委 比 -68.67%
- 總股本 4049.63万
- 歷史最高 19.9992
- 量 比 0.45
- 振 幅 6.02%
- 歷史最低 1.70
- 每 手 1
- 風險率 0.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多OnKure Therapeutics Q2 EPS $0.31 Beats $(0.54) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.54) by 158.49 percent. This is a 127.19 percent increase over losses of $(1.14) per share from the same period last year.
08-05 04:28
美股大行评级 | 伯恩斯坦上调Robinhood目标价从130美元升至160美元；纽约梅隆银行、Datadog、五三银行、旅行者财产险集团获多家机构上调评级
今日重点评级关注：Needham：维持Immuneering"买入"评级，目标价从11美元升至18美元；富瑞：维持塞德斯医疗"买入"评级，目标价从90美元升至100美元
07-21 11:36
HC Wainwright & Co. Maintains Buy on OnKure Therapeutics, Lowers Price Target to $21
HC Wainwright & Co. analyst Robert Burns maintains OnKure Therapeutics (NASDAQ:OKUR) with a Buy and lowers the price target from $27 to $21.
07-20 23:52
OnKure Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.
OnKure Therapeutics shares are trading lower after the company reported worse-t...
05-06 23:23
OnKure Therapeutics Q1 EPS $(1.11) Misses $(0.64) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.64) by 73.44 percent. This is a 6.72 percent increase over losses of $(1.19) per share
05-06 04:39
OnKure Therapeutics Enters Into Securities Purchase Agreement For Private Placement Raising Gross Proceeds Of ~$150M
-- Financing led by Access Biotechnology with participation from new and existing investors-- Financing to support advancement of two next-generation PI3Kα pan-mutant inhibitors for breast cancer and vascular anomalies –
03-27 20:12
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Micron To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Monday
Top analysts updated ratings for MU, EPAM, WLTH, OKUR, BLDR, DMRC, JBIO, CRCL. See changes and ratings on analyst ratings page.
03-16 20:12
'[HC Wainwright & Co. Maintains Buy on OnKure Therapeutics, Lowers Price Target to $27
HC Wainwright & Co. analyst Robert Burns maintains OnKure Therapeutics (NASDAQ:OKUR) with a Buy and lowers the price target from $34 to $27.
03-16 19:27
OnKure Therapeutics Q4 EPS $(0.99) Misses $(0.75) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.75) by 32 percent. This is a 27.74 percent increase over losses of $(1.37) per share
03-13 04:16
